Eli Lilly’s Verzenio Picks Up Third Approved Indication Post author:Sam Post published:February 26, 2018 Post category:BioPharma Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace You Might Also Like Five Prime Tanked on Early Peek of Lead Drug Data November 7, 2017 How Much Cash Kite Pharma's Execs Made From Its $12 Billion Gilead Deal September 28, 2017 Top 3 Takeover Targets for Pfizer January 22, 2018
